BlackRock, Inc. 13D and 13G filings for Ironwood Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | BlackRock Inc. BLK | 22,918,324 14.300% | 0 (Unchanged) | Filing |
| 2024-10-23 5:04 pm Sale | 2024-09-30 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | BlackRock Inc. BLK | 22,918,324 14.300% | -3,060,575 (-11.78%) | Filing |
| 2024-01-22 2:03 pm Purchase | 2023-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | BlackRock Inc. BLK | 25,978,899 16.600% | 207,707 (+0.81%) | Filing |
| 2023-01-26 08:52 am Unchanged | 2022-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | BlackRock Inc. BLK | 25,771,192 16.800% | 0 (Unchanged) | Filing |
| 2023-01-20 5:17 pm Sale | 2022-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | BlackRock Inc. BLK | 25,771,192 16.800% | -1,123,895 (-4.18%) | Filing |
| 2022-07-08 4:57 pm Purchase | 2022-06-30 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | BlackRock Inc. BLK | 26,895,087 17.500% | 12,526,197 (+87.18%) | Filing |
| 2022-02-02 7:11 pm Purchase | 2021-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | BlackRock Inc. BLK | 14,368,890 8.800% | 1,324,240 (+10.15%) | Filing |
| 2021-01-29 5:23 pm Sale | 2020-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | BlackRock Inc. BLK | 13,044,650 8.100% | -496,895 (-3.67%) | Filing |